An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004
Clinical trial NCT03596164 · COMPLETED
Trial details
- NCT number
- NCT03596164
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-09
- Primary completion
- 2022-01-13
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.